Literature DB >> 27317743

Promiscuous or discriminating: Has the favored mRNA target of Fragile X Mental Retardation Protein been overlooked?

Aoife C McMahon1, Michael Rosbash2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27317743      PMCID： PMC4932994          DOI： 10.1073/pnas.1607665113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  17 in total

Review 1.  Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Authors:  Michael R Santoro; Steven M Bray; Stephen T Warren
Journal:  Annu Rev Pathol       Date:  2011-10-10       Impact factor: 23.472

2.  Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons.

Authors:  Ricardos Tabet; Enora Moutin; Jérôme A J Becker; Dimitri Heintz; Laetitia Fouillen; Eric Flatter; Wojciech Krężel; Violaine Alunni; Pascale Koebel; Doulaye Dembélé; Flora Tassone; Barbara Bardoni; Jean-Louis Mandel; Nicolas Vitale; Dominique Muller; Julie Le Merrer; Hervé Moine
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-27       Impact factor: 11.205

Review 3.  Dysregulation and restoration of translational homeostasis in fragile X syndrome.

Authors:  Joel D Richter; Gary J Bassell; Eric Klann
Journal:  Nat Rev Neurosci       Date:  2015-09-09       Impact factor: 34.870

4.  Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice.

Authors:  Lujian Liao; Sung Kyu Park; Tao Xu; Peter Vanderklish; John R Yates
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

5.  Correction of fragile X syndrome in mice.

Authors:  Gül Dölen; Emily Osterweil; B S Shankaranarayana Rao; Gordon B Smith; Benjamin D Auerbach; Sumantra Chattarji; Mark F Bear
Journal:  Neuron       Date:  2007-12-20       Impact factor: 17.173

6.  Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome.

Authors:  Bin Tang; Tingting Wang; Huida Wan; Li Han; Xiaoyan Qin; Yaoyang Zhang; Jian Wang; Chunlei Yu; Fulvia Berton; Walter Francesconi; John R Yates; Peter W Vanderklish; Lujian Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-11       Impact factor: 11.205

7.  FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.

Authors:  Jennifer C Darnell; Sarah J Van Driesche; Chaolin Zhang; Ka Ying Sharon Hung; Aldo Mele; Claire E Fraser; Elizabeth F Stone; Cynthia Chen; John J Fak; Sung Wook Chi; Donny D Licatalosi; Joel D Richter; Robert B Darnell
Journal:  Cell       Date:  2011-07-22       Impact factor: 41.582

8.  FMRP targets distinct mRNA sequence elements to regulate protein expression.

Authors:  Manuel Ascano; Neelanjan Mukherjee; Pradeep Bandaru; Jason B Miller; Jeffrey D Nusbaum; David L Corcoran; Christine Langlois; Mathias Munschauer; Scott Dewell; Markus Hafner; Zev Williams; Uwe Ohler; Thomas Tuschl
Journal:  Nature       Date:  2012-12-12       Impact factor: 49.962

9.  Fmrp targets or not: long, highly brain-expressed genes tend to be implicated in autism and brain disorders.

Authors:  Rebecca L Ouwenga; Joseph Dougherty
Journal:  Mol Autism       Date:  2015-03-11       Impact factor: 7.509

Review 10.  Diacylglycerol kinase as a possible therapeutic target for neuronal diseases.

Authors:  Yasuhito Shirai; Naoaki Saito
Journal:  J Biomed Sci       Date:  2014-04-07       Impact factor: 8.410
View more
  2 in total

1.  Loss of Drosophila FMRP leads to alterations in energy metabolism and mitochondrial function.

Authors:  Eliana D Weisz; Atif Towheed; Rachel E Monyak; Meridith S Toth; Douglas C Wallace; Thomas A Jongens
Journal:  Hum Mol Genet       Date:  2018-01-01       Impact factor: 6.150

2.  ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.

Authors:  Ya-Ping Pei; Yue-Yi Wang; Dan Liu; Hui-Yang Lei; Zhi-Hao Yang; Zi-Wei Zhang; Man Han; Ke Cheng; Yu-Shan Chen; Jin-Quan Li; Gui-Rong Cheng; Lang Xu; Qing-Ming Wu; Shawn M McClintock; Ying Yang; Yong Zhang; Yan Zeng
Journal:  J Neurosci       Date:  2019-12-27       Impact factor: 6.167
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.